Chiesi UK

Chiesi is a research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions for chronic and genetic diseases. Working across respiratory health, rare diseases and speciality care, our medicines are delivered to patients in over 100 countries worldwide. We are driven by the concept of shared value; making decisions based on what is best for our business, the planet, patients, and people. As a B Corp, we’re part of a global community of businesses that meet high standards of social and environmental impact, and we have an ambitious yet robust plan to become a Net Zero company by 2035. Our UK business was established in 1999 and has grown to a team of around 400 people based in our head office in Manchester, a research and development centre in Chippenham and a network of field-based teams. Our people are our greatest strength, and our workplace is purposeful, equitable, and diverse. We are proud to have been recognised year after year as an outstanding employer, receiving numerous accolades from internationally recognised authorities such as Great Place to Work®. In 2024, we were named within the top 25 World’s Best Workplaces™ – the first time any European pharmaceutical company has achieved this ranking. Community guidelines: https://lnkd.in/e4pPzSKJ